Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Giridhar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015- University of California (San Francisco)Internship, Internal Medicine, 2012 - 2013
University of Pittsburgh School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2014 - Present
MN State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2016-2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2016-2017
Publications & Presentations
PubMed
- ASO Visual Abstract: Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of...Christopher D Vetter, Tanya Hoskin, Carrie Olson, Karthik Giridhar, Judy C Boughey
Annals of Surgical Oncology. 2026-01-01 - Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advan...Manali Bhave, Komal L Jhaveri, Peter A Kaufman, Philippe Aftimos, Janine Lombard
Breast Cancer Research. 2025-12-21 - HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and Answers.Nusayba A Bagegni, Karthik V Giridhar, Daphne Stewart
Cancers. 2025-12-17
Press Mentions
A More Personalized Approach to Breast Cancer CareJanuary 6th, 2025- Debunking Myths About CancerJune 10th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
